Vitaherpavac is the first Russian herpes simplex virus vaccine obtained on the Vero ? continuous cell line

Voprosy Virusologii

Volumn 54, Issue 5, 2009, Pages 33-37

  Barkhaleva, O A ^a   Ladyzhenskaya, I P ^a   Vorobyeva, M S ^a   Shalunova, N V ^a   Podchernyaeva, R Ya ^b   Mikhailova, G R ^b   Khorosheva, T V ^c   Barinsky, I F ^a  

^a Tarasevic State Institute for the Standardization and Control of Medical Biological Preparations   (France)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c ZAO Vitafarma Firn   (Russian Federation)

Author keywords

Continuous cell line; Herpes simplex virus; Primary trypsinized cell culture; Vaccine

Indexed keywords

HERPES; SIMPLEXVIRUS;

HERPES SIMPLEX VACCINE; INACTIVATED VACCINE; VITAHERPAVAC;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CERCOPITHECUS; CHRONIC DISEASE; CLINICAL TRIAL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME; VERO CELL;

ADOLESCENT; ADULT; ANIMALS; CERCOPITHECUS AETHIOPS; CHRONIC DISEASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INJECTIONS, INTRADERMAL; MIDDLE AGED; TREATMENT OUTCOME; VACCINES, INACTIVATED; VERO CELLS;

EID: 73349098464     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)